BMS secures EU approval for Yervoy
This article was originally published in Scrip
Executive Summary
As expected, Bristol-Myers Squibb has secured from European regulators approval of Yervoy (ipilimumab) for the treatment of adult patients with previously-treated advanced melanoma.